RCS - Spectral MD Holdings - Mediscience Award Win

Spectral MD HoldingsAnnouncement

17/06/2022 10:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220617:nRSQ2898Pa&default-theme=true

RNS Number : 2898P  Spectral MD Holdings, Ltd.  17 June 2022

 

Spectral MD Holdings, Ltd

("Spectral MD" or the "Company" or the Group")

 

Mediscience Award Win

Spectral MD win Best Technology award at the European Mediscience Awards

 

LONDON, U.K AND DALLAS, TX, U.S. Spectral MD Holdings, Ltd. (AIM: SMD), a
predictive analytics company that develops proprietary AI algorithms and
optical technology for faster and more accurate treatment decisions in wound
care, announces that it has won the Best Technology award at the European
Mediscience Awards, held at Hotel InterContinental, London, last night.

 

The Best Technology award is awarded for a technology that is innovative, well
funded, and capable of significant commercial success even if it is not yet
proven. The technology concerned could have been developed within the
organization or acquired. Spectral MD received the award for its DeepView(®)
Wound Imaging System, a predictive analytics platform that combines AI
algorithms and medical imaging for wound prediction.

The European Mediscience Awards is the largest annual gathering of private and
publicly quoted healthcare, biotech and life sciences companies in Europe,
bringing together the best European mediscience companies to celebrate
achievement and recognise success.

Wensheng Fan, Chief Executive Officer of Spectral MD, commented: "I was
delighted to collect this award last night on behalf of the Spectral MD team.
This award is a testament to the passion and hard work of the Spectral MD team
and the fantastic technology that we continue to develop. We are honored to be
recognized on an international stage at such a prestigious event."

 

For further information please contact:

 

 Spectral MD Holdings, Ltd.                                                     investors.spectralmd.com
 Wensheng Fan, Chief Executive Officer                                          via Walbrook PR
 Nils Windler, Chief Financial Officer

 Walbrook PR Ltd (Media & Investor Relations)      Tel: +44 (0)20 7933 8780 or spectralMD@walbrookpr.com
 Paul McManus / Sam Allen                          Mob: +44 (0)7980 541 893 / +44 (0)7502 558 258

 Alice Woodings                                    +44 (0)7407 804 654

 

 

About Spectral MD:
 

We are a dedicated team of forward-thinkers striving to revolutionize the
management of wound care by "Seeing the Unknown" ® with our DeepView(®)
Wound Imaging System.

www.spectralmd.com

info@spectralmd.com

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAUBOKRUKUNARR